+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cystic Neoplasm"

From
Mucinous cystic neoplasms (MCNs) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Mucinous cystic neoplasms (MCNs) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Cystic neoplasms are a type of tumor that can occur in the pancreas, ovary, and other organs. They are usually benign, but can sometimes be malignant. Cystic neoplasms can cause pain, nausea, and other symptoms, and can be difficult to diagnose. Treatment options include surgery, chemotherapy, and radiation therapy. The cystic neoplasm market within the context of oncology is a rapidly growing field. It is driven by the increasing prevalence of cystic neoplasms, as well as advances in diagnosis and treatment. The market is expected to benefit from the development of new drugs and treatments, as well as the increasing availability of personalized medicine. Companies in the cystic neoplasm market include Roche, Novartis, AstraZeneca, Merck, and Pfizer. Show Less Read more